Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non–Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing

@inproceedings{ShajaniYi2018FrequencyOS,
  title={Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non–Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing},
  author={Zahra Shajani-Yi and Francine B. de Abreu and J. Darrel Peterson and Gregory J. Tsongalis},
  booktitle={Neoplasia},
  year={2018}
}
The tumor suppressor gene TP53 is the most frequently mutated gene in human cancer. It encodes p53, a DNA-binding transcription factor that regulates multiple genes involved in DNA repair, metabolism, cell cycle arrest, apoptosis, and senescence. TP53 is associated with human cancer by mutations that lead to a loss of wild-type p53 function as well as mutations that confer alternate oncogenic functions that enable them to promote invasion, metastasis, proliferation, and cell survival… CONTINUE READING
BETA
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 41 REFERENCES

TP53: an oncogene in disguise

  • Cell Death and Differentiation
  • 2015
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Rescuing the function of mutant p53

  • Nature Reviews Cancer
  • 2001
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

Thermodynamic stability of wild-type and mutant p53 core domain.

  • Proceedings of the National Academy of Sciences of the United States of America
  • 1997
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

TP53 mutational status is predictive of pazopanib response in advanced sarcomas.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2016

Similar Papers

Loading similar papers…